Skip to content
healthcare.dev

Dexlansoprazole delayed release

NDC 24979-001, dexlansoprazole, capsule, delayed release, from Upsher-Smith Laboratories, LLC.

Product NDC
24979-001
Status
Listed
Labeler
Upsher-Smith Laboratories, LLC
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202666
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24979-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXLANSOPRAZOLE30 mg/1

Pharmacologic classes

Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
24979-001-062497900010630 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24979-001-06)
24979-001-072497900010790 CAPSULE, DELAYED RELEASE in 1 BOTTLE (24979-001-07)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/8dca4887-c75a-4021-8564-b704e9e1fa3e
  • NADAC price for package 24979000106

    GET /v1/drugs/nadac/24979000106

Use it

Look up 24979-001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24979-001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24979-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.